TSX closed
Loading markets…

Advertisement

Stocks

Southern Cross Gold Announces Date of Annual Shareholders Meeting

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:SXGC.TO

Follow SXGC

Photos provided by Pexels

Southern Cross Gold has set the date for its Annual Shareholders Meeting.

Southern Cross Gold Consolidated Ltd. has announced the date for its upcoming Annual Shareholders Meeting. This event will give investors a chance to learn about the company's plans and performance. The company's shares closed at C$10.50, down 1.32% for the day and 6.67% over the past week.

Advertisement

Southern Cross Gold Consolidated Ltd.

SXGC.TO

Full stock page →

SXGC.TO

Southern Cross Gold Consolidated Ltd.

Source:WealthAwesomeWealthAwesome
↓ $0.70 (-6.25%)
120 day period
$8.03$10.61$13.18Apr 20Jul 15Oct 8

Market cap

$2.87B

52W high

$13.60

52W low

$6.16

1W change

-6.67%

Analyst Price Targets

Based on analyst covering SXGC · as of Sep 24, 2026

📈

Wall Street analysts forecast SXGC stock price to rise 31.7% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$13.83

+31.7% Upside

Previously C$13.81 on Sep 21, 2026

Current Price

C$10.50

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on SXGC's historical volatility

HistoricalForecast68%95%
C$6.61C$10.05C$13.49C$16.93C$20.37C$23.81TodayJun 2Aug 6Oct 8Nov 20Jan 3Feb 15

30-Day Vol

51.1%

Annualized

90-Day Vol

71.8%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$12.55

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$11.14C$9.34 – C$13.29
60 trading daysC$11.83C$9.22 – C$15.18
90 trading daysC$12.55C$9.25 – C$17.03

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should pay attention to the meeting outcomes for clues about the company's future direction.

Last close at C$10.50, down 1.32% for the day.

Volume for the day was 461,147 shares, below the 20-day average of 558,061 shares.

Bull case

The announcement of the meeting suggests that the company values transparency and is eager to engage with shareholders. This could help build investor confidence.

Bear case

However, ongoing negative performance trends may overshadow any potential positive impacts from the meeting.

Annual Shareholders Meeting Announced

Advertisement

Southern Cross Gold has officially announced the date for its Annual Shareholders Meeting. This meeting is important because it allows shareholders to interact directly with the company’s management team. The outcomes could shed light on Southern Cross Gold's strategic direction and operational priorities. Investors will be particularly interested in the company’s plans, especially given the current stock performance, with shares trading at C$10.50.

Current Stock Performance Overview

As mentioned, Southern Cross Gold's shares closed at C$10.50, reflecting a 1.32% decline for the day. Over the past week, the stock has dropped by 6.67%, and it has fallen 10.49% in the last month. Currently, the stock is trading below its 50-day moving average of C$11.71, indicating a 10.3% discount. On the other hand, it is slightly above its 200-day moving average of C$10.27, which is a 2.3% premium. The stock is positioned within a 52-week range of C$6.16 to C$13.60.

What to Watch Going Forward

Investors will likely focus on the discussions and resolutions during the Annual Shareholders Meeting. The outcomes could provide valuable insights into the company's strategic direction and operational priorities. Analysts have set an average target price of C$13.83 for the stock, suggesting a potential upside of 31.7% from the last closing price. Additionally, the stock has a market capitalization of C$2.87 billion, with a profit margin of 0.0% and a return on equity of -2.2%, highlighting areas for improvement.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 9, 2026
Last Updated: October 9, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement